No Data
No Data
Express News | Anavex Life Sciences Announces Appointment of DR. Audrey Gabelle, Md, Phd to the Scientific Advisory Board
Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle East
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years
Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital
Anavex Life Sciences Is Maintained at Buy by D. Boral Capital